A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
Clinical trial NCT03897868 · COMPLETED
Trial details
- NCT number
- NCT03897868
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-21
- Primary completion
- 2020-02-26
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.